Koller, Lorenz <br/><br/>
Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.  [electronic resource] 

 -  Circulation. Heart failure  Nov 2015 
 - 1059-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-3297 
<br/><br/><label>Standard No.: </label>10.1161/CIRCHEARTFAILURE.115.002341  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Biomarkers--blood<br/>Cohort Studies<br/>Female<br/>Fibroblast Growth Factor-23<br/>Fibroblast Growth Factors--blood<br/>Heart Failure--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Predictive Value of Tests<br/>Risk Factors<br/>Stroke Volume--physiology<br/>Survival Analysis